Supplementary Figure S2 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
September 16, 2024
Supplementary Figure S2 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Kaplan-Meier curve of progression-free survival (PFS) among patients with long-term response (LTR) in the combined cohort.
Preguntar a la IA
Me gusta
Guardar
Compartir
Cite This Study
Thummalapalli et al. (Mon,) studied this question.